Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Inventory (2016 - 2025)

Historic Inventory for HUTCHMED (China) (HCM) over the last 12 years, with Q2 2025 value amounting to $48.5 million.

  • HUTCHMED (China)'s Inventory rose 433.45% to $48.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $48.5 million, marking a year-over-year increase of 433.45%. This contributed to the annual value of -$772000.0 for FY2024, which is 11866.99% down from last year.
  • According to the latest figures from Q2 2025, HUTCHMED (China)'s Inventory is $48.5 million, which was up 433.45% from -$772000.0 recorded in Q4 2024.
  • In the past 5 years, HUTCHMED (China)'s Inventory registered a high of $53.9 million during Q2 2023, and its lowest value of -$21.2 million during Q4 2022.
  • In the last 5 years, HUTCHMED (China)'s Inventory had a median value of $22.6 million in 2021 and averaged $20.6 million.
  • Over the last 5 years, HUTCHMED (China)'s Inventory had its largest YoY gain of 463142.2% in 2021, and its largest YoY loss of 34167.82% in 2021.
  • Over the past 5 years, HUTCHMED (China)'s Inventory (Quarter) stood at -$16.0 million in 2021, then tumbled by 32.56% to -$21.2 million in 2022, then skyrocketed by 119.49% to $4.1 million in 2023, then crashed by 118.67% to -$772000.0 in 2024, then surged by 6376.42% to $48.5 million in 2025.
  • Its Inventory was $48.5 million in Q2 2025, compared to -$772000.0 in Q4 2024 and $46.4 million in Q2 2024.